Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.40 |
| ▸ | NPC1 | O15118 | 2/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 3/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 4/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.37 |
| ▸ | MEN1 | O00255 | 2/20 | 0.37 |
| ▸ | ELANE | P08246 | 1/20 | 0.36 |
| ▸ | USP2 | O75604 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6519684 | 0.88 | L3MBTL1 (0.39) | TDP1NPC1RAB9ALMNAALDH1A1 | |
| SCHEMBL6518605 | 0.85 | L3MBTL1 (0.42) | TDP1NPC1RAB9ASMN1; SMN2LMNA | |
| SCHEMBL6516178 | 0.85 | LMNA (0.44) | TDP1SMN1; SMN2LMNAALDH1A1GAA | |
| SCHEMBL7044014 | 0.82 | ALDH1A1 (0.38) | TDP1NPC1LMNAALDH1A1L3MBTL1 | |
| SCHEMBL6518797 | 0.76 | MGAM (0.38) | LMNAALDH1A1L3MBTL1GAAKMT2A | |
| SCHEMBL6514852 | 0.76 | TSHR (0.33) | SMN1; SMN2ALDH1A1 | |
| SCHEMBL6524022 | 0.75 | TSHR (0.32) | LMNA | |
| SCHEMBL6518880 | 0.74 | GAA (0.51) | TDP1NPC1RAB9ASMN1; SMN2LMNA | |
| SCHEMBL7044012 | 0.74 | ALDH1A1 (0.38) | LMNAALDH1A1L3MBTL1GAAKMT2A | |
| SCHEMBL6513746 | 0.73 | GAA (0.50) | TDP1NPC1RAB9ASMN1; SMN2LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6958366-B2 | Antifouling coating composition and novel resin | DAINIPPON INK AND CHEMICALS, INC. (JP) | 2005-10-25 | — | — | US | disclosed |
| US-20030118544-A1 | Antifouling coating composition and novel resin | DAINIPPON INK AND CHEMICALS, INC. (JP) | 2003-06-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030118544-A1 | Antifouling coating composition and novel resin | COL1A1, GLRA1, COL2A1 | TDP1 1789/4885NPC1 3563/4885RAB9A 2333/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.